Menu

Testing Endurance

Researchers follow 44 ultramarathon runners in a race across Europe to track the body's response to extreme physical challenge.

Jul 26, 2012
Hayley Dunning

During the Trans Europe Foot Race, runners cover more than 4,487 kilometers (2,788 miles) from southern Italy to North Cape, Norway. For the 2009 race, 44 of those runners submitted to daily health examinations, including MRI scans with a mobile scanner, ice-water pain tests, and blood and urine analyses. The project, detailed last week (July 19) in BioMed Medicine, was divided into four modules:

  • Musculoskeletal system: to investigate potential damage to joints, bones, and soft tissues in the legs
  • Brain, mind, and pain perception: to investigate changes in the volume of the brain, damage caused by lesions, pain perception, and mental stress
  • Cardiovascular system: to assess the effects of stress on the heart and arterial wall strength
  • Body composition: to track changes in muscle mass and body fat
While the huge resulting data set is still being looked at from every angle, the researchers have released some preliminary results. Of studied runners that didn't finish the race, the most common reason was inflammation of the leg tissues due to overuse. Two runners fractured bones, but because of their high pain tolerance, they ran over 200 more kilometers before giving up. Some runners who experienced leg inflammation were able to continue running, and it eventually cleared up.

The data will be used to assess the course of breakdown and regeneration in such injuries, as well as provide insights into the susceptibility to injury between individuals. By looking into the brain, the researchers also hope to investigate the hormonal influence resulting from endurance exercise.

"This pioneering study will assess the impact of extreme endurance on human physiology," wrote Andrew Murray and Ricardo Costa in an editorial for BioMed Medicine. "The results will be of interest not only to endurance runners, but to anyone interested in the limits of human performance."

Correction (July 30, 2012): This story has been updated from its original version to correctly reflect the journal name as BioMed Medicine, not BioMed Central Medicine. The Scientist regrets the error.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.